Extract
With high prevalence and high burden, the condition we call chronic obstructive pulmonary disease (COPD) is not so much a respiratory concern as a public-health epidemic [1]. This is particularly true in low- and middle-income countries (LMICs) where most cases remain undiagnosed and untreated. With recent changes to the Global Initiative for Chronic Obstructive Lung Disease (GOLD) definition of COPD [2], and publication of the Lancet Commission on COPD [1], we review the current state of the art in relation to COPD definition and diagnosis, and why remaining inconsistencies matter.
Abstract
Current definitions of COPD are not consistent with diagnostic criteria, contributing to confusion in clinical practice and research https://bit.ly/3IkrZqD
Footnotes
Conflict of interest: S. Ananth has nothing to disclose.
Conflict of interest: J.R. Hurst reports consulting fees from AstraZeneca and GSK; lecture honoraria from Boehringer Ingelheim, Chiesi and Takeda; travel support and advisory board membership with AstraZeneca; and donation of oximeters from Nonin; outside the submitted work.
- Received December 2, 2022.
- Accepted February 1, 2023.
- Copyright ©The authors 2023. For reproduction rights and permissions contact permissions{at}ersnet.org